SCHEMBL5283339

SCHEMBL5283339

NCCC(NCCc1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.50
HRH1 P35367 2/20 0.47
SIGMAR1 Q99720 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 2/20 0.46
MAOA P21397 2/20 0.46
NPC1 O15118 1/20 0.46
KDM1A O60341 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
CYP2C8 P10632 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
IDO1 P14902 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
PTGS1 P23219 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5049798 0.86 SIGMAR1 (0.49) KCNH2SIGMAR1SMN1; SMN2ALDH1A1MAOA
SCHEMBL12637361 0.82 HRH1 (0.52) KCNH2HRH1SMN1; SMN2ALDH1A1LMNA
SCHEMBL20725540 0.80 KCNH2 (0.44) KCNH2SIGMAR1SMN1; SMN2ALDH1A1MAOA
SCHEMBL8135255 0.77 HRH1 (0.52) KCNH2HRH1SIGMAR1SMN1; SMN2ALDH1A1
SCHEMBL17821183 0.75 ALDH1A1 (0.49) SIGMAR1SMN1; SMN2ALDH1A1MAOANPC1
SCHEMBL4915574 0.75 L3MBTL1 (0.51) KCNH2HRH1SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL1878622 0.75 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1ATMEPHX2
SCHEMBL11203104 0.74 HRH1 (0.54) HRH1SMN1; SMN2LMNACYP1A2CYP3A4
Hydrochloric Acid SCHEMBL10782582 0.74 L3MBTL1 (0.50) KCNH2HRH1SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL7616722 0.74 RAB9A (0.71) KCNH2SIGMAR1SMN1; SMN2ALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007006544-A2 CYCLIC ADENOSINE MONOPHOSPHATE COMPOUNDS FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS VRIJE UNIVERSITEIT BRUSSEL (BE) 2007-01-18 WO claimed
WO-2007006544-A2 CYCLIC ADENOSINE MONOPHOSPHATE COMPOUNDS FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS VRIJE UNIVERSITEIT BRUSSEL (BE) 2007-01-18 WO disclosed